Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmin Gill

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
JAMA Network Open|April 15, 2022
Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck CancerSung Jun Ma, Han Yu, Michael Khan, et al.
JAMA Network Open|June 27, 2023
Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapySung Jun Ma, Michael Khan, Udit Chatterjee, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
JAMA Network Open|December 8, 2022
Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck CancerSung Jun Ma, Han Yu, Brian Yu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
JAMA Network Open|April 15, 2022
Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck CancerSung Jun Ma, Han Yu, Michael Khan, et al.
JAMA Network Open|June 27, 2023
Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapySung Jun Ma, Michael Khan, Udit Chatterjee, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
JAMA Network Open|December 8, 2022
Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck CancerSung Jun Ma, Han Yu, Brian Yu, et al.
Pageof 2